Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2026Nano LIFE

Lymphatic-Targeted Nanoparticle Drug Delivery for Early Cancer Metastasis and Lymphoma: Bypassing Hepatic First-Pass Metabolism

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBishal SinghTwitter (United States)ASAbhisekh SahTwitter (United States)BGBijoy Ghosh

Discussion

Loading...

Member takes

Implication

Review evaluates lymphatic-targeted nanoparticle delivery for better outcomes in cancer metastasis and lymphoma, suggesting a novel intervention.

Key Points

  • This review discusses lymphatic-targeted nanoparticle drug delivery systems aimed at improving chemotherapy for early cancer metastasis and lymphoma.
  • Analyzed properties of lymphatic-targeted nanoparticles including size, charge, and surface chemistry.
  • Reviewed key nanoplatforms such as liposomes, dendrimers, and solid lipid nanoparticles.
  • Discussed pharmacokinetic advantages of bypassing hepatic metabolism through various administration routes.
  • Lymphatic-targeted nanoparticles can achieve better drug concentrations in lymph nodes compared to standard therapies.
  • The review highlights advancements in active targeting using lymphatic endothelial cell receptors.
  • Emerging clinical evidence supports the effectiveness of rationally-designed nanoparticles in precision lymphatic oncology.

Cite This Study

Singh et al. (2026) studied this question.

synapsesocial.com/papers/6a36324adb0793dc1a538fcchttps://doi.org/10.1142/s1793984426300141
View Full Paper
Ask AI
Bookmark
Share